跳至主要内容
临床试验/CTRI/2020/04/024880
CTRI/2020/04/024880尚未招募未知

Standard versus low dose cyclical cyclophosphamide and steroids in the treatment of primary membranous nephropathy- a randomized controlled trial. - Nil

Dr Manu Dogra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Either sex with biopsy proven primary MGN.
  • 2. Persistent nephrotic syndrome despite non-immunosuppressive adjuvant treatment for 3 months or earlier due to complications requiring hospitalisation.
  • 3. After informed and written consent.

排除标准

  • 1.Patients with eGFR < 45 ml/min/1.73m2
  • 2.Prior, active infection including hepatitis B/C and HIV infection
  • 3.Positive for anti-nuclear factor
  • 4.Monoclonal proteins in serum/urine
  • 5.Any suggestion of malignancy on ultrasonography
  • 6.Hypocomplementemia
  • 7.Presence of tubular atrophy and interstitial fibrosis in >1/3rd biopsy area
  • 8.Pre-existing DM
  • 9.Abnormal liver function tests and secondary MN
  • 10.Any immunosuppressive therapy in the last 12 months
  • 11.Female of childbearing age who has a pregnancy plan, or is pregnant, or lactating.

研究者

发起方
Dr Manu Dogra

相似试验